Barclays’s Aspire Biopharma Holdings, Inc. Warrant ASBPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16K | Hold |
350,000
| – | – | ﹤0.01% | 4110 |
|
|
2025
Q1 | $31K | Hold |
350,000
| – | – | ﹤0.01% | 3993 |
|
|
2024
Q4 | $17K | Hold |
350,000
| – | – | ﹤0.01% | 4130 |
|
|
2024
Q3 | $15K | Hold |
350,000
| – | – | ﹤0.01% | 4100 |
|
|
2024
Q2 | $3.95M | Hold |
350,000
| – | – | ﹤0.01% | 1296 |
|
|
2024
Q1 | $11K | Hold |
350,000
| – | – | ﹤0.01% | 4001 |
|
|
2023
Q4 | $21K | Hold |
350,000
| – | – | ﹤0.01% | 3966 |
|
|
2023
Q3 | $18K | Hold |
350,000
| – | – | ﹤0.01% | 3931 |
|
|
2023
Q2 | $18K | Hold |
350,000
| – | – | ﹤0.01% | 3991 |
|
|
2023
Q1 | $15K | Hold |
350,000
| – | – | ﹤0.01% | 4037 |
|
|
2022
Q4 | $28K | Hold |
350,000
| – | – | ﹤0.01% | 3964 |
|
|
2022
Q3 | $39K | Hold |
350,000
| – | – | ﹤0.01% | 3734 |
|
|
2022
Q2 | $60K | Buy |
+350,000
| New | +$60K | ﹤0.01% | 3661 |
|